| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs12141041 |
alpha-hydroxyisovalerate |
T/C |
7222 |
0.47 |
-0.025 (0.004) |
1.77·10-12 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs12141041 |
| Chromosomal location | Chr1: 119,754,299 (1p12) |
| Gene (distance) | HAO2 (16,026) |
| Predicted causal gene | HAO2 |
| Gene/protein classification | - |
| Metabolite (Pathway) | alpha-hydroxyisovalerate (Valine, leucine and isoleucine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | HAO2 encodes a 2-hydroxyacid oxidase which catalyzes the oxidation of L-alpha-hydroxy acids; alpha-hydroxyisovalerate or a related metabolite may be a potential substrate [10777549]. |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL2021745 |
| Drug information |
Compounds with low inhibitory activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |